Clinical Trial Update: Intracoronary Administration of Levosimendan in Cardiac Surgery Patients [Phase 4]

View source ↗

Summary

Phase 4 trial update on intracoronary administration of levosimendan in cardiac surgery patients was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Stunning

Drugs mentioned

• Levosimendan (levosimendan)

Snippet

Sponsor: Tampere University Hospital | Conditions: Myocardial Stunning | Phase 4 | Status: TERMINATED